Evidence map›Paper›PMID 19272192›Full record

ArticleJournal of biomedical science2009

An integrated method for cancer classification and rule extraction from microarray data.

Liang-Tsung Huang

Abstract readEvaluation Study
In one paragraph

Article in Journal of biomedical science, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Liang-Tsung HuangDepartment of Computer Science and Information Engineering, Mingdao University, Changhua 523, Taiwan. larry@mdu.edu.tw

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Different microarray techniques recently have been successfully used to investigate useful information for cancer diagnosis at the gene expression level due to their ability to measure thousands of gene expression levels in a massively parallel way. One important issue is to improve classification performance of microarray data. However, it would be ideal that influential genes and even interpretable rules can be explored at the same time to offer biological insight. Introducing the concepts of system design in software engineering, this paper has presented an integrated and effective method (named X-AI) for accurate cancer classification and the acquisition of knowledge from DNA microarray data. This method included a feature selector to systematically extract the relative important genes so as to reduce the dimension and retain as much as possible of the class discriminatory information. Next, diagonal quadratic discriminant analysis (DQDA) was combined to classify tumors, and generalized rule induction (GRI) was integrated to establish association rules which can give an understanding of the relationships between cancer classes and related genes. Two non-redundant datasets of acute leukemia were used to validate the proposed X-AI, showing significantly high accuracy for discriminating different classes. On the other hand, I have presented the abilities of X-AI to extract relevant genes, as well as to develop interpretable rules. Further, a web server has been established for cancer classification and it is freely available at http://bioinformatics.myweb.hinet.net/xai.htm.

Indexed as

LeukemiaOligonucleotide Array Sequence AnalysisSoftwareAlgorithmsArtificial IntelligenceComputational BiologyDatabases, GeneticGene Expression ProfilingHumansInternetMolecular Sequence DataReproducibility of Results

Identifiers

PMID19272192
PMCPMC2653531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.